Gevo, Inc. (NASDAQ: GEVO) is a Basic Materials company in the Chemicals - Specialty industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | - | EPS (ttm) | -0.14 | Insider Own | 6.65% | Shs Outstand | 243.41M | Perf Week | 4.03% |
| Market Cap | 377.29M | Forward P/E | - | EPS next Y | -0.06 | Insider Trans | -6.38% | Shs Float | 231.57M | Perf Month | 8.39% |
| Enterprise Value | 468.29M | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 11.53% | Perf Quarter | -25.12% |
| Income | -34.00M | P/S | 2.17 | EPS this Y | 6.54% | Inst Trans | - | Short Ratio | 7.59 | Perf Half Y | -18.85% |
| Sales | 174.00M | P/B | 0.83 | EPS next Y | 55.55% | ROA | -5.17% | Short Interest | 26.70M | Perf YTD | -22.50% |
| Book/sh | 1.87 | P/C | 4.78 | EPS next 5Y | - | ROE | -7.28% | 52W High | 2.97 -47.81% | Perf Year | 27.05% |
| Cash/sh | 0.32 | P/FCF | - | EPS past 3/5Y | - | ROIC | -1.28% | 52W Low | 1.12 38.39% | Perf 3Y | -5.49% |
| Dividend Est. | - | EV/EBITDA | 29.27 | Sales past 3/5Y | 444.01% 93.08% | Gross Margin | 47.31% | Volatility | 6.23% 6.55% | Perf 5Y | -73.23% |
| Dividend TTM | - | EV/Sales | 2.69 | EPS Y/Y TTM | 58.82% | Oper. Margin | -4.62% | ATR (14) | 0.11 | Perf 10Y | -99.30% |
| Dividend Ex-Date | - | Quick Ratio | 3.51 | Sales Y/Y TTM | 923.53% | Profit Margin | -19.38% | RSI (14) | 49.62 | Recom | 2.29 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.31 | EPS Q/Q | 44.44% | SMA20 | -0.99% | Beta | 1.02 | Target Price | 2.88 |
| Payout | 0.00% | Debt/Eq | 0.35 | Sales Q/Q | 48.28% | SMA50 | -1.06% | Rel Volume | 0.97 | Prev Close | 1.46 |
| Employees | 151 | LT Debt/Eq | 0.35 | Earnings | Aug 06 | SMA200 | -20.24% | Avg Volume | 3.47M | Price | 1.55 |
| IPO Date | Feb 09, 2011 | Option/Short | No / Yes | EPS/Sales Surpr. | -104.11% -4.34% | Net Debt/EBITDA | 5.71 | Volume | 3,345,660 | Change | 6.16% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-16-26 | Reiterated | Northland Securities | Outperform | $3.50 → $3.75 |
| May-22-26 | Reiterated | UBS | Neutral | $2.25 → $2.00 |
| Apr-16-26 | Reiterated | Northland Capital Markets | Outperform | $3.00 → $3.50 |
| Dec-01-25 | Initiated | Northland | Outperform | $3.00 |
| Apr-23-24 | Reiterated | Stifel Nicolaus | $1.50 | |
| Dec-14-22 | Reiterated | UBS | Neutral | $2.25 |
| Feb-10-22 | Reiterated | Citigroup | Buy | $5.00 |
| Sep-07-18 | Upgrade | HC Wainwright & Co. | Neutral → Buy | |
| Jan-09-18 | Downgrade | H.C. Wainwright | Buy → Neutral | |
| Jun-19-13 | Downgrade | Raymond James | Outperform → Market Perform |
Gevo, Inc. is a company focused on the development and commercialization of renewable fuels. Its operations are organized into four distinct segments: Gevo, Agri-Energy, Renewable Natural Gas, and Net-Zero. The company's primary objective is to offer sustainable alternatives for gasoline, jet fuel, and diesel, striving to achieve zero carbon emissions and substantially lower overall greenhouse gas footprints. Their diverse product offerings include renewable versions of gasoline and diesel, sustainable aviation fuel (SAF), and renewable natural gas. Additionally, they produce specialty chemicals like isooctane, isobutanol, isobutylene, and ethanol, along with animal feed and protein. Gevo, Inc. has formed a strategic partnership with Axens North America, Inc. to advance ethanol-to-jet technology and further the commercial development of sustainable aviation fuel projects. Originally founded in 2005 as Methanotech, Inc., the company changed its name to Gevo, Inc. in March 2006. Its corporate headquarters are located in Englewood, Colorado.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 174 | 161 | 17 | 17 | 1 | 1 | 6 | 24 | 33 | |
| Cost of Goods Sold Incl. D&A | 91 | 112 | 12 | 12 | 9 | 8 | 15 | 37 | 42 | |
| Gross Profit | 83 | 49 | 5 | 5 | -8 | -7 | -9 | -12 | -9 | |
| Selling, General and Administrative Excl. Other | 57 | 51 | 46 | 43 | 40 | 25 | 11 | 10 | 8 | |
| Research and Development | 11 | 5 | 24 | 7 | 17 | 17 | 4 | 4 | 5 | |
| Other Operating Expense | 22 | 11 | 26 | 37 | 38 | 11 | 2 | 0 | 0 | |
| Operating Income | -8 | -19 | -91 | -82 | -103 | -60 | -27 | -26 | -22 | |
| Interest Expense | 19 | 18 | 4 | 2 | 1 | 0 | 2 | 3 | 3 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -5 | 4 | 16 | 18 | 6 | 1 | -11 | 0 | -3 | |
| Net Income Before Taxes | -32 | -33 | -79 | -66 | -98 | -59 | -40 | -29 | -28 | |
| Income Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Consolidated Net Income | -34 | -34 | -79 | -66 | -98 | -59 | -40 | -29 | -28 | |
| Net Income From Continuing Operations | -32 | -33 | -79 | -66 | -98 | -59 | -40 | -29 | -28 | |
| Net Income | -34 | -34 | -79 | -66 | -98 | -59 | -40 | -29 | -28 | |
| EPS (Recurring) | -0.14 | -0.14 | -0.34 | -0.28 | -0.44 | -0.30 | -0.71 | -2.58 | -5.74 | |
| EPS (Basic, Before Extraordinaries) | -0.14 | -0.14 | -0.34 | -0.28 | -0.44 | -0.30 | -0.71 | -2.58 | -5.74 | |
| EPS (Diluted) | -0.14 | -0.14 | -0.34 | -0.28 | -0.44 | -0.30 | -0.71 | -2.58 | -5.74 | |
| EBITDA | 16 | 10 | -56 | -45 | -89 | -54 | -32 | -19 | -18 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 2.11 | 2.91 | 28.52 | 16.31 | 421.80 | 838.88 | 40.38 | 1.16 | 0.30 | |
| Gross Margin | 47.70 | 30.43 | 29.41 | 29.41 | -800.00 | -700.00 | -150.00 | -50.00 | -27.27 | |
| Operating Margin | -4.60 | -11.80 | -535.29 | -482.35 | -10,300.00 | -6,000.00 | -450.00 | -108.33 | -66.67 | |
| Net Margin | -19.54 | -21.12 | -464.71 | -388.24 | -9,800.00 | -5,900.00 | -666.67 | -120.83 | -84.85 | |
| Shares Outstanding | 237 | 234 | 232 | 239 | 222 | 196 | 57 | 12 | 5 | |
| Market Capitalization | 367 | 468 | 485 | 277 | 422 | 839 | 242 | 28 | 10 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Gruber Patrick R. | Director | Jun 12 '26 | Sale | 1.40 | 157,563 | 220,856 | 3,571,430 | Jun 15 |
| Ryan Christopher Michael | President & COO | Jun 12 '26 | Sale | 1.43 | 35,196 | 50,161 | 1,279,245 | Jun 15 |
| Bloom Paul D | CEO | Jun 12 '26 | Sale | 1.43 | 35,189 | 50,151 | 1,483,399 | Jun 15 |
| Bowron Kimberly T | Chief of Staff | Jun 12 '26 | Sale | 1.43 | 15,470 | 22,048 | 696,295 | Jun 15 |
| Agiri Oluwagbemileke Yusuf | CFO | Jun 12 '26 | Sale | 1.40 | 63,028 | 88,075 | 491,116 | Jun 15 |
| Shafer Andrew | Chief Mktg Cust & Brnd Officer | Jun 12 '26 | Sale | 1.43 | 9,443 | 13,458 | 311,608 | Jun 15 |
| Gendenjamts Davaajargal | VP Acctg and Treasurer | Jun 12 '26 | Sale | 1.43 | 4,293 | 6,118 | 108,865 | Jun 15 |
| Gruber Patrick R. | Director | May 27 '26 | Sale | 1.76 | 186,469 | 328,148 | 3,728,993 | May 29 |
| Shafer Andrew | Chief Mktg Cust & Brnd Officer | May 27 '26 | Sale | 1.76 | 32,667 | 57,487 | 321,051 | May 29 |
| Bowron Kimberly T | Chief of Staff | May 27 '26 | Sale | 1.76 | 25,101 | 44,173 | 711,765 | May 29 |
| Agiri Oluwagbemileke Yusuf | CFO | May 27 '26 | Sale | 1.77 | 31,958 | 56,652 | 554,144 | May 29 |
| Ryan Christopher Michael | President & COO | May 27 '26 | Sale | 1.76 | 87,700 | 154,334 | 1,314,441 | May 29 |
| Bloom Paul D | CEO | May 27 '26 | Sale | 1.76 | 75,735 | 133,278 | 1,518,588 | May 29 |
| Shafer Andrew | Chief Cust Mkt & Brnd Officer | May 01 '26 | Option Exercise | 0.71 | 5,550 | 3,941 | 276,373 | May 01 |
| Shafer Andrew | Chief Cust Mkt & Brnd Officer | May 01 '26 | Sale | 2.00 | 5,550 | 11,103 | 270,823 | May 01 |